| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |